250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in China in July 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in China. We rank investors based on the number of investments they made in Medical device companies from China. We update this investor list every month.

Top 50 Medical Device Startup Investors in China in July 2025

Investor Medical Device China investments
Cowin Capital 13
Qiming Venture Partners 12
HSG 12
CD Capital 10
BioVenture 10
BIOCHING CAPITAL 9
Shunwei Capital 9
Lilly Asia Ventures 9
BioTrack Capital 8
Haibang Capital 8
Prox Ventures 7
IDG Capital 7
Dalton Venture 7
Jan Hammer 7
Legend Capital 7
Med-Fine Capital 7
Matrix Partners China 6
Marathon Venture Partners 6
Share Capital 6
Addor Capital 6
Taiyu Investment 6
Sunland Fund 5
SND Ventures Group 5
Fortune Venture Capital 5
SZHTI Group 5
Goldport Capital 5
CDH Investments 5
Apricot Capital 5
Oriza Holdings 4
Oriza Seed Capital (Oriza Yuandian) 4
Taiyu Investment 4
Qiaojing Capital 4
Insight Capital 4
Volcanics Venture 4
Frees Fund 4
Huagai Capital 4
ASBV 4
EFung Capital 4
Highlight Capital 4
HY Capital 4
Shenzhen Capital Group 3
BGI Co-Win 3
Huaige Capital 3
Tasly Capital 3
Yunnan Botanee Bio Technology Group 3
CASH Capital 3
Northern Light Venture Capital 3
Chiron Ventures 3
Jinding Capital 3
Tiantu Capital 3
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Cowin Capital VC Fund · Shenzhen, Guangdong, China · 32 investments in the past 12 months
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Series B, Seed
  • China, Hong Kong, United States
Portfolio highlights
  • Tsinghua Huahe — Tsinghua Huahe is a medical devices company that provides research and development of modified PEEK materials.
  • Hangrun Aviation — Hangrun Aviation specializes in aviation engine inspection and maintenance, including engine disassembly, sales, exchange, leasing, maintenance management, and other services.
  • Zhongke Chuncui Technology — Zhongke Chuncui Technology is ahigh-tech enterprise focusing on the efficient separation and extraction of new energy strategic metals.
Qiming Venture Partners VC Fund · Shanghai, Shanghai, China · 59 investments in the past 12 months
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series B, Series A, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
  • Tianchen Biotechnology — Tianchen Biotechnology is a biotech company that specializes in the research, design, development, and sales of ophthalmology-related medical products. It provides complete diagnostic and treatment solutions for ophthalmology.
HSG VC Fund · Beijing, Beijing, China · 28 investments in the past 12 months
We help founders build enduring companies.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Manus AI — Manus is a general AI agent that turns your thoughts into actions. It excels at various tasks in work and life, getting everything done while you rest.
  • Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
CD Capital VC Fund · Shanghai, Shanghai, China
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
  • Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
  • Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
BioVenture VC Fund · Suzhou, Jiangsu, China · 8 investments in the past 12 months
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Taiwan
Portfolio highlights
  • AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
  • Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
  • Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
BIOCHING CAPITAL VC Fund · Longgang, Guangdong, China · 3 investments in the past 12 months
BIOCHING CAPITAL is an investment management firm.
Show more
Investment focus
  • Medical Device, Biotechnology, Medical
  • Angel, Series A, Seed
  • China
Portfolio highlights
  • Taose Tuantuan — Taose Tuantua is a sex toy company that primarily offers TAOSETT sex toy academy and exquisite sex toy community store services.
  • Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
  • Qinglan Jichuang — Qinglan Jichuang is a domestic high-performance intelligent endoscope innovative enterprise.
Shunwei Capital VC Fund · Beijing, Beijing, China · 22 investments in the past 12 months
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more
Investment focus
  • Manufacturing, Software, Internet
  • Series A, Series B, Series C
  • China, India, United States
Portfolio highlights
  • HOTO — HOTO Home Tools specializes in creating innovative home tools with a focus on modern design and smart functionality. The company aims to transform everyday gadgets into aesthetically pleasing and highly functional devices, catering to the needs of contemporary households. HOTO's product range includes a variety of tools designed to enhance theefficiency and convenience of home maintenance and DIY projects. By integrating smart technology into their products, HOTO Home Tools seeks to provide users with an improved and more intuitive tool-using experience, making home improvement tasks simpler and more enjoyable.
  • Yijian Health — Yijian Health is a one-stop precision medicine service platform. Its core products include genetic testing services and LIMS system software. It is mainly engaged in gene sequencing for individualized medication guidance for tumors, women and children, infections, chronic diseases and other diseases, providing professional testing for the generalpublic. Serve.
  • Beipei Technology — Beipei Technology offers children educational and companion toys that combine software and hardware, aiming to make significant breakthroughs in the field of educational toys.
Lilly Asia Ventures VC Fund · Shanghai, Shanghai, China · 9 investments in the past 12 months
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
  • Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
  • Timberlyne Therapeutics — Taking Best-in-Class Therapies to New Heights Our mission is to bring life-changing medicines to patients living with autoimmune diseases. About Us Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise
BioTrack Capital VC Fund · Shanghai, Shanghai, China · 7 investments in the past 12 months
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Singapore
Portfolio highlights
  • Spurious — Sipurui is a pharmaceutical company specializing in the development of small molecule anti-tumor drugs, with a particular emphasis on iterative innovation to enhance the efficacy and selectivity of cancer therapies.
  • Cavan Auto — Cavan Auto specializes in the production of electric vehicles and hydrogen fuel cell-powered new energy.
  • Sirius Therapeutics — Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.
Haibang Capital VC Fund · Hangzhou, Zhejiang, China
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Angel, Series B
  • China
Portfolio highlights
  • MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
  • Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
  • Jianxin Jiaren — Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation.
Prox Ventures VC Fund · Shanghai, Shanghai, China
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
  • Medical, Biotechnology, Health Care
  • Seed, Funding Round, Series A
  • China, United States, United Kingdom
Portfolio highlights
  • Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
  • Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
  • Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
IDG Capital VC Fund · Beijing, Beijing, China · 15 investments in the past 12 months
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
  • Software, Internet, E-Commerce
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Sand.ai — Sand AI is an AI company that focuses on producing videos.
  • Kaia — Kaia is a public blockchain that utilizes Byzantine Fault Tolerance (BFT) for enhanced reliability and performance.
  • Wanhai Medical — Wanhai Medical is a prominent manufacturer specializing in the development and production of self-medication injection systems.
Dalton Venture VC Fund · Shanghai, Shanghai, China · 8 investments in the past 12 months
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Seed, Series A, Series B
  • India, China, Canada
Portfolio highlights
  • Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Jan Hammer Angel · London, England, United Kingdom · 12 investments in the past 12 months
Jan joined Index in 2010, and is a London-based partner, focusing on fintech and information/data services across all stages of growth.He is one of Index Ventures’ leading fintech investors, working with the founders of Adyen, Credit Benchmark, Robinhood and TransferWise. In all, Index has backed more than two dozen fintech companies, withmore than $400 million. Jan has also led Index investments and is on the boards of Beamery, Collibra, SafetyCulture and Silverfin.Before he joined Index, Jan was at General Atlantic in London, where he worked on investments in Kaspersky Lab, Northgate Information Solutions and Torex Retail. He also worked in the M&A, TMT and Capital Markets divisions at Morgan Stanley. Jan is a graduate of Oxford University, and holds an MBA with Distinction from INSEAD.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China, United States, United Kingdom
Portfolio highlights
  • MacroLux — MacroLux Medical Technology Co., Ltd.
  • Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
  • Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Legend Capital VC Fund · Beijing, Beijing, China · 21 investments in the past 12 months
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series B, Series A, Series C
  • China, United States, South Korea
Portfolio highlights
  • Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
  • Force Inspiration — Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robotmanufacturing and sales.
  • Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
Med-Fine Capital VC Fund · Shanghai, Shanghai, China · 4 investments in the past 12 months
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
  • Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
Matrix Partners China VC Fund · Beijing, Beijing, China · 12 investments in the past 12 months
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Series C
  • China, United States, Hong Kong
Portfolio highlights
  • Sand.ai — Sand AI is an AI company that focuses on producing videos.
  • TOYA — TOYA specializes in the production of ultra-fine copper and copper alloy conductors.
  • LeXiang Intelligence — LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.
Marathon Venture Partners VC Fund · Shanghai, Shanghai, China · 2 investments in the past 12 months
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Angel
  • China, United States, Hong Kong
Portfolio highlights
  • Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
  • Kangai Medical — Kangai Medical specialises on clinical nutrition and rehabilitation
  • Femtosecond Technology — Femtosecond Technology is a developer of label-free biological imaging technology.Femtosecond Technology is a high-tech, "specialized and innovative" firm focusing on the application of femtosecond laser technology in clinical diagnosis and treatment, as well as biomedical industrialization.
Share Capital VC Fund · Shenzhen, Guangdong, China
Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Colombia
Portfolio highlights
  • Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
  • Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
  • Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.
Addor Capital VC Fund · Nanjing, Jiangsu, China · 34 investments in the past 12 months
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more
Investment focus
  • Manufacturing, Semiconductor, Electronics
  • Series A, Series B, Funding Round
  • China, Hong Kong, United States
Portfolio highlights
  • PaXini Tech — All Scenario Application—Haptic Digitization and Tactile Technology
  • Landong Precision — Landong Precision is a specialized high-tech enterprise engaged in the design, development, and manufacturing of key components for gas circuits, vacuum systems, and specialized equipment used in semiconductor device production. With a strong emphasis on precision engineering and advanced manufacturing processes, Landong Precision provideshigh-performance parts that meet the stringent requirements of the semiconductor industry.
  • Isoftstone Intelligent Computing — Isoftstone Intelligent Computing is a subsidiary of Isoftstone Information Technology Group Co., Ltd that focuses on artificial intelligence infrastructure construction and innovative services.
Taiyu Investment VC Fund · 4 investments in the past 12 months
Taiyu Investment is an investment firm.
Show more
Investment focus
  • Medical, Medical Device, Biotechnology
  • Series A, Angel, Seed
  • China
Portfolio highlights
  • NeuroPlus — NeuroPlus is a developer of bioelectric sensing technologies, with an emphasis on new applications such as precise EEG measurement, smart wearables, and mobile medical care.
  • Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
  • Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
Sunland Fund VC Fund · Shanghai, Shanghai, China
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Seed
  • China
Portfolio highlights
  • Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
  • Juhe Biotechnology — Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies.
  • Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
SND Ventures Group VC Fund · Suzhou, Jiangsu, China · 10 investments in the past 12 months
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more
Investment focus
  • Manufacturing, Semiconductor, Health Care
  • Series B, Series A, Seed
  • China
Portfolio highlights
  • Kossel Medical — Kossel Medical is a medical device R&D, manufacturer of vascular interventional devices to provide clinical system solutions.
  • Algebraist Coffee — Algebraist Coffee focuses on developing and producing excellent coffee with high-quality coffee beans from around the world
  • Jianzhen Machinery — Jianzhen Machinery is a high-end equipment manufacturing company that focuses on the manufacturing of ultra-precision structural parts.
Fortune Venture Capital VC Fund · Shenzhen, Guangdong, China · 21 investments in the past 12 months
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more
Investment focus
  • Manufacturing, Information Technology, Software
  • Series A, Series B, Seed
  • China, Japan, United States
Portfolio highlights
  • ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
  • Strongest Laser — Strongest Laser is a high-power fiber laser equipment developer.
  • Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
SZHTI Group VC Fund · Shenzhen, Guangdong, China · 5 investments in the past 12 months
SZHTI Group is a company that provides asset management and financing services.
Show more
Investment focus
  • Manufacturing, Electronics, Semiconductor
  • Series A, Angel, Funding Round
  • China, United States
Portfolio highlights
  • StarDetect — StarDetect is a space-based computing platform that provides full-process satellite-based intelligent application service solutions.
  • Sanyuan Aerospace — Sanyuan Aerospace is an aerospace service provider with a core business in space operation technologies, space operation-related equipment development, and space on-orbit service business operations.
  • Damo Intelligent Control — Damo Intelligent Control is a national specialized "little giant" enterprise and a national high-tech enterprise focusing on the research and development, production, sales, and service integration of drone cluster automation performance systems. It is the world's leading supplier of drone cluster automation performance systems.
Goldport Capital VC Fund · Shenzhen, Guangdong, China · 5 investments in the past 12 months
Goldport Capital is a Shenzhen-based asset management company.
Show more
Investment focus
  • Manufacturing, Medical, Semiconductor
  • Series A, Seed, Series B
  • China
Portfolio highlights
  • Yisite Biotech — Yisite Biotech is a technology-driven enterprise that concentrates on advancements in the field of synthetic biology.
  • Chaoguang Micro — Chaoguang Micro specializes in the innovative development of optical products for medical and industrial purposes.
  • Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.
CDH Investments VC Fund · Kowloon City, Kowloon, Hong Kong · 20 investments in the past 12 months
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
  • Manufacturing, Biotechnology, Health Care
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Robot Era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
  • Tiejin Technology — Tiejin Technology is a humanoid robotics company that provides research and development related to micro and ultra-micro bearings.
  • Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Apricot Capital VC Fund · Shanghai, Shanghai, China
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • China, United States, Hong Kong
Portfolio highlights
  • Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
  • Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
  • Simcere Pharma — Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.
Oriza Holdings VC Fund · Suzhou, Jiangsu, China · 16 investments in the past 12 months
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Series B, Series C
  • China, United States, Canada
Portfolio highlights
  • Magic Atom — Magic Atom is a robotics company that specializes in the development and application of robots and embodied intelligent technologies.
  • Scanner Optics Co.,Ltd — Scanner Optics is professional in galvanometer scanners, controllers, software, optics, encoders and customized galvanometer systems. Our galvo scanner products have been applied in many industries: laser marking, laser cutting, laser welding, laser scanning, 3D printing and so on. Contact Scanner Optics now!
  • AECC Commercial Aircraft Engine — AECC offers design, development, production, assembly, testing, and technical consulting of commercial aircraft power services.
Oriza Seed Capital (Oriza Yuandian) VC Fund · Suzhou, Jiangsu, China · 18 investments in the past 12 months
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more
Investment focus
  • Manufacturing, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
  • Scanner Optics Co.,Ltd — Scanner Optics is professional in galvanometer scanners, controllers, software, optics, encoders and customized galvanometer systems. Our galvo scanner products have been applied in many industries: laser marking, laser cutting, laser welding, laser scanning, 3D printing and so on. Contact Scanner Optics now!
  • Xili Optoelectronics — Xili Optoelectronics is a pioneering company focused on the development of advanced, future-oriented optical engine system integrated chips (OE-SICs) that deliver high bandwidth and low energy consumption.
Taiyu Investment VC Fund · Beijing, Beijing, China
Taiyu Investment is an investment firm.
Show more
Investment focus
  • Medical, Health Care, Biotechnology
  • Series A, Seed, Angel
  • China
Portfolio highlights
  • Immorna — Immorna specializes in the production of RNA-based therapeutics.
  • ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
  • Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Qiaojing Capital VC Fund · Shanghai, Shanghai, China
Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Series B, Angel
  • China
Portfolio highlights
  • Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
  • Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
  • Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
Insight Capital VC Fund · Beijing, Beijing, China · 2 investments in the past 12 months
Insight Capital is a venture capital firm focused on early-stage investment.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Series C
  • China
Portfolio highlights
  • Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
  • Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
  • Iongen Therepeutics — Iongen Therepeutics is an innovative drug research and development company focusing on pain treatment.
Volcanics Venture VC Fund · Changning, Shanghai, China
Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Series B, Seed
  • China, United States
Portfolio highlights
  • Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
  • Unisic — Unisic designs and manufactures silicon carbide core power components. Unisic develops sets of products based on silicon carbide and has applied silicon carbide power modules to aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, data centers, and other important fields.
  • Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .
Frees Fund VC Fund · Beijing, Beijing, China · 15 investments in the past 12 months
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
  • Artificial Intelligence, Medical, Biotechnology
  • Series A, Seed, Angel
  • China, United States, Singapore
Portfolio highlights
  • Boin Biotechnology — Boin Biotechnology is a cutting-edge biopharmaceutical company. The company is dedicated to the development of gene therapy drugs, with a particular focus on advancing the next generation of gene therapy.
  • Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
  • Dingou Biopharmaceuticals — Dingou Biotechnology is a developer of allergen diagnosis and treatment products, mainly engaged in allergen-specific diagnosis and treatment business
Huagai Capital VC Fund · Beijing, Beijing, China · 4 investments in the past 12 months
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Seed
  • China, United States, Germany
Portfolio highlights
  • Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
  • ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
  • Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
ASBV VC Fund · Shenzhen, Guangdong, China
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Series A, Angel
  • China, Australia, Hong Kong
Portfolio highlights
  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
EFung Capital VC Fund · Shenzhen, Guangdong, China
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series A, Series B, Series C
  • China, United States, India
Portfolio highlights
  • Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
  • CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
  • Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
Highlight Capital VC Fund · Nanjin, Jiangsu, China · 21 investments in the past 12 months
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, Portugal
Portfolio highlights
  • ENGINEAI — ENGINEAI is committed to advancing the commercialization of humanoid robot technology worldwide.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
  • Shenandoah Therapeutics — Shenandoah Therapeutics is a biotechnology company.
HY Capital VC Fund · Changning, Shanghai, China · 3 investments in the past 12 months
HY Capital is a healthcare industry-focused investment firm that engages in early-stage investments, growth-stage investments.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series A, Seed, Series B
  • China, United States
Portfolio highlights
  • Kang Ruijian — Kang Ruijian is a developer of thermosensitive modified chitin hydrogel technology.
  • Onico Medical — Onico Medical is a medical device developer. The core team comes from the serious medical field and has absorbed professionals with rich experience in medical aesthetics development.
  • Linyan Medical — Linyan Medical is a high-tech company focusing on the combination of man and machine in metaverse medical surgery.
Shenzhen Capital Group VC Fund · Shenzhen, Guangdong, China · 13 investments in the past 12 months
Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
  • Guangdong Xinyue — Xinyueneng manufactures silicon carbide chips and conducts research and development in the automotive and industrial control industries.
  • Aerospace China Electronics — Aerospace China Electronics is a chip solution vendor that serves the military and civilian industries for Internet of Things connectivity, security, and terminal intelligence.
BGI Co-Win VC Fund · Shenzhen, Guangdong, China
BGI Co-Win is the corporate venture capital arm of BGI and is based in Shenzhen, China.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Series A, Seed, Angel
  • China
Portfolio highlights
  • LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
  • Yingshu Life — Yingshu Life is a research and development manufacturer of minimally invasive medical devices.
  • Waker Biology — Weike Bio is a gene therapy drug development company.
Huaige Capital VC Fund · Shanghai, Shanghai, China
Huaige Capital is a venture capital focusing on healthcare sector.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Angel, Funding Round
  • China
Portfolio highlights
  • Affinity — Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs.
  • Xianyan Biopharma — Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff.
  • Xinhengrui Medical — Xinhengrui Medical provides heart-assisted medical devices and offers complete, safe, and effective intelligent mechanical-assisted therapy solutions for heart failure patients.
Tasly Capital VC Fund · Tianjin, Guangdong, China
Tasly Capital is an investment arm of Tasly, a Chinese pharmaceutical company.
Show more
Investment focus
  • Health Care, Medical, Medical Device
  • Series B, Seed, Series A
  • China
Portfolio highlights
  • EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
  • PulseCare — PulseCare is a medtech company that specializes in innovative medical devices and solutions for cardiac and pan-vascular treatment.
  • Deco Medical — Deco Medical is a myocardial repair service provider and an innovative medical device research and development enterprise.
Yunnan Botanee Bio Technology Group VC Fund · Kunming, Yunnan, China
Yunnan Bethany Biotechnology is a healthcare company that manufactures skin care products for sensitive skin, acne, barrier damage, stubborn spots, and fragile skin. They provide a scientific care programs for certain skin problems and develop effective and safe skin care products.
Show more
Investment focus
  • Medical, Medical Device, Health Care
  • Series A, Corporate Round
  • China
Portfolio highlights
  • Weimu Medical — Weimu Medical is a high-end interventional medical device developer.
  • Dieckmann — Dieckmann is a manufacturer of functional small-molecule raw materials.
  • Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
CASH Capital VC Fund · Beijing, Beijing, China
CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage.
Show more
Investment focus
  • Health Care, Biotechnology, Manufacturing
  • Series A, Series B, Series C
  • China, United States
Portfolio highlights
  • Gene Cradle — Gene Cradle is a genetic company that develops gene therapy drugs to treat rare genetic diseases as well as chronic diseases.
  • Century Yunan — Century Yunan is a new energy vehicle charging solution provider.
  • Beijing KYKY Technology — KYKY is a supplier of vacuum acquisition and testing products for the Chinese market. Its products are relevant for electro-optics, ion optics, vacuum physics, and other technical engineering projects.
Northern Light Venture Capital VC Fund · Beijing, Beijing, China · 3 investments in the past 12 months
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Seed
  • China, United States, South Korea
Portfolio highlights
  • VOC AI — VOC AI offers AI tools for ecommerce insights and customer service solutions.
  • AscentStream — AscentStream is a software development company that provides cloud messaging software and stream processing solutions.
  • Shengrun New Materials — Shengrun New Materials is an aerogel material and system solution service provider integrating advanced material process research and development, product application development, advanced production line design, and mature system solutions.
Chiron Ventures VC Fund · Beijing, Beijing, China
Chiron Ventures is an investment firm specializes in innovation and investment in medical health.Chiron Ventures has accumulated rich experience and resources in medical technology development, medical innovation and entrepreneurship, and medical market development, providing substantial support and professional value-added services for itsinvestment projects.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A, Seed, Angel
  • China, Australia, United States
Portfolio highlights
  • Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
  • Ren Labs — Empowering projects to create a limitless future for the decentralized web.
  • Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.
Jinding Capital VC Fund · Beijing, Beijing, China · 10 investments in the past 12 months
Jinding Capital is a leading industrial equity investment institution in China.
Show more
Investment focus
  • Manufacturing, Health Care, Pet
  • Series A, Series B, Seed
  • China
Portfolio highlights
  • Himiao — Himiao is a pet industry-focused company that offers pet items. its aim to create a healthier and happier life for pets and pet lovers.
  • Daimeng Robot — Daimeng Robot is dedicated to creating multi-series general-purpose humanoid robot products that are actually commercially available and concentrate on their research and production. It offers a comprehensive selection of goods and cutting-edge answers for situations including intelligent manufacturing, logistics, and commercial services.
  • Huaban Biotechnology — Huaban Biotech is dedicated to the innovative research and development of new materials for medical aesthetics.
Tiantu Capital VC Fund · Shenzhen, Guangdong, China
Tiantu Capital is a venture capital association.
Show more
Investment focus
  • Food and Beverage, E-Commerce, Health Care
  • Series A, Series B, Series C
  • China, United States, Japan
Portfolio highlights
  • Recorna Bio — Recorna Bio specializes in biotechnology, focusing on RNA editing and genome modifications through advanced research and development. They aim to innovate in genetic engineering, contributing to advancements in biomedicine and agriculture with cutting-edge technologies and scientific expertise.
  • Leman Biotech — Leman Biotech is a biotech company that is engaged in development of cancer immunotherapies.
  • Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Investors by industry
Investors by country
Investors in China by industry